These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1891 related articles for article (PubMed ID: 33935138)

  • 1. Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.
    Shioda K; Lau MSY; Kraay ANM; Nelson KN; Siegler AJ; Sullivan PS; Collins MH; Weitz JS; Lopman BA
    Epidemiology; 2021 Jul; 32(4):518-524. PubMed ID: 33935138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies.
    Shioda K; Lau MS; Kraay AN; Nelson KN; Siegler AJ; Sullivan PS; Collins MH; Weitz JS; Lopman BA
    medRxiv; 2020 Nov; ():. PubMed ID: 33236035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
    Lim T; Delorey M; Bestul N; Johannson MA; Reed C; Hall AJ; Fry AM; Edens C; Semenova V; Li H; Browning P; Desai R; Epperson M; Jia T; Thornburg NJ; Schiffer J; Havers FP
    Clin Infect Dis; 2021 Nov; 73(10):1831-1839. PubMed ID: 33639620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.
    Chamberlain AT; Toomey KE; Bradley H; Hall EW; Fahimi M; Lopman BA; Luisi N; Sanchez T; Drenzek C; Shioda K; Siegler AJ; Sullivan PS
    J Infect Dis; 2022 Feb; 225(3):396-403. PubMed ID: 34662409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
    Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
    Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
    J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut.
    Mahajan S; Caraballo C; Li SX; Dong Y; Chen L; Huston SK; Srinivasan R; Redlich CA; Ko AI; Faust JS; Forman HP; Krumholz HM
    Am J Med; 2021 Jun; 134(6):812-816.e2. PubMed ID: 33617808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020-December 2020.
    Sullivan PS; Siegler AJ; Shioda K; Hall EW; Bradley H; Sanchez T; Luisi N; Valentine-Graves M; Nelson KN; Fahimi M; Kamali A; Sailey C; Lopman BA
    Clin Infect Dis; 2022 Apr; 74(7):1141-1150. PubMed ID: 34245245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
    Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.
    Tuite AR; Fisman D; Abe KT; Rathod B; Pasculescu A; Colwill K; Gingras AC; Yi QL; O'Brien SF; Drews SJ
    Microbiol Spectr; 2022 Feb; 10(1):e0256321. PubMed ID: 35196819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
    Erikstrup C; Hother CE; Pedersen OBV; Mølbak K; Skov RL; Holm DK; Sækmose SG; Nilsson AC; Brooks PT; Boldsen JK; Mikkelsen C; Gybel-Brask M; Sørensen E; Dinh KM; Mikkelsen S; Møller BK; Haunstrup T; Harritshøj L; Jensen BA; Hjalgrim H; Lillevang ST; Ullum H
    Clin Infect Dis; 2021 Jan; 72(2):249-253. PubMed ID: 33501969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Stone M; Di Germanio C; Wright DJ; Sulaeman H; Dave H; Fink RV; Notari EP; Green V; Strauss D; Kessler D; Destree M; Saa P; Williamson PC; Simmons G; Stramer SL; Opsomer J; Jones JM; Kleinman S; Busch MP;
    Clin Infect Dis; 2022 Mar; 74(5):871-881. PubMed ID: 34111244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada.
    Zinszer K; Charland K; Pierce L; Saucier A; McKinnon B; Hamelin MÈ; Cheriet I; Da Torre MB; Carbonneau J; Nguyen CT; De Serres G; Papenburg J; Boivin G; Quach C
    Int J Infect Dis; 2023 Jun; 131():119-126. PubMed ID: 36963656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California.
    Lamba K; Bradley H; Shioda K; Sullivan PS; Luisi N; Hall EW; Mehrotra ML; Lim E; Jain S; Kamali A; Sanchez T; Lopman BA; Fahimi M; Siegler AJ
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab379. PubMed ID: 34377733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
    Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.
    Havers FP; Reed C; Lim T; Montgomery JM; Klena JD; Hall AJ; Fry AM; Cannon DL; Chiang CF; Gibbons A; Krapiunaya I; Morales-Betoulle M; Roguski K; Rasheed MAU; Freeman B; Lester S; Mills L; Carroll DS; Owen SM; Johnson JA; Semenova V; Blackmore C; Blog D; Chai SJ; Dunn A; Hand J; Jain S; Lindquist S; Lynfield R; Pritchard S; Sokol T; Sosa L; Turabelidze G; Watkins SM; Wiesman J; Williams RW; Yendell S; Schiffer J; Thornburg NJ
    JAMA Intern Med; 2020 Jul; ():. PubMed ID: 32692365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.